XTL BIOPHARMACEUTICALS LTD. Adjustments For Decrease Increase In Prepaid Expenses
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Adjustments For Decrease Increase In Prepaid Expenses of -$58.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses · last filed 2025-04-30
| Period end | Adjustments For Decrease Increase In Prepaid Expenses 12 month |
|---|---|
| 2024-12-31 | -$58.00K 20-F · filed 2025-04-30 |
| 2023-12-31 | $45.00K 20-F · filed 2025-04-30 |
| 2022-12-31 | $25.00K 20-F · filed 2025-04-30 |